During the run-up to the HLM (High-Level Meeting) on AMR during UNGA 2024 (the UN General Assembly, September 2024, see the 15 Apr 2023 newsletter for details), I thought it would be useful to have a list of major reports that had been released to inform those discussions. I am sure I am going to miss things (at least initially), so please drop me a note (john.rex@13.43.35.2) if you want to see something added to this list. Thanks, —jr

• Reports (mostly) Focused on AMR related to human health
• Manufacturing
  • 05 Jun 2023: Antibiotic Manufacturing Certification
    •  The AMR Industry Alliance has worked with BSI Standards to develop a certification process for safe discharge during antibiotic manufacturing.
    • Press release, website, 25 Sep 2023 newsletter
• Stewardship and Access
  •  22 Mar 2021: Stewardship & Access Guide
    • From CARB-X, Wellcome, And Partners, this is the definitive guide
    • The 22 Mar 2021 newsletter is the best starting point; it also includes a video chat about the new guidelines
  • Feb 2024: Equitable & Responsible Access Roadmap
    • The AMR Industry Alliance‘s roadmap covers diagnostics, drugs, and procurement.
    • The document itself
• R&D: Push, Pull, and People
  • 07 Sep 2023: Overcoming Resistance
    • This one could have been subtitled “How Canada should Pull for new antibiotics”!
    • Webpage, report, one-pager on the report, short slide deck, and 8 Sep 2023 newsletter.
    • Report author: Canadian Council of Academies (CCA)
  • 21 Sep 2023: A New Grand Bargain to Improve the Antimicrobial Market for Human Health
    • Tackles the question of “Why would any given group take action to support an antibiotic ecosystem?” from the perspective of High-Income Countries (HICs), Low- and Middle-Income Countries (LMICs), Pharmaceutical companies, and International Organizations.
    • Webpage, report, and 5 Nov 2023 newsletter.
    • Report author: Center for Global Development (CGD)
  • 15 Nov 2023: Value and sustainability of antibiotics as essential tools for the healthcare system and people’s health
    • This one could have been subtitled “How Italy should Push and Pull as it takes the 2024 G7 chair“!
    • Webpage, full report (in Italian), press release (in English), one-page policy brief (in English), and 7 Dec 2023 newsletter.
    • Report author: The European House – Ambrosetti
  • 08 Feb 2014: Leaving the Lab: Tracking the Decline in AMR R&D Professionals
    • As you can infer from this title, this one summarizes the alarming multi-year decline in the number of active AMR R&D professionals.
    • Press release, report, and 8 Feb 2024 newsletter.
  • 15 Feb 2024: 2024 AMR Preparedness Index Progress Report
    • Updates a 2021 survey on progress on National Action Plans, Push-Pull, Access, Appropriate Use, and Environmental Protection by 11 countries (Brazil, Canada, China, France, Germany, India, Italy, Japan, South Korea, UK, US).
    • Press release, report, and 15 Feb 2024 newsletter.
    • Report authors: Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA)
  • 22 Feb 2024: The Economics of Antibiotic Resistance
    • A superb tour of way an economist (and hence a Finance Minister) would view AMR as a Market Failure
    • Webpage, paper, blog, and 28 Feb 2024 newsletter
    • Report authors: For the Center for Global Development (CGD), Anthony McDonnell, Ranil Dissanayake, Katherine Klemperer, Flavio Toxvaerd, and Michael Sharland
  • 25 Mar 2024: Effective antibiotics for the Swiss health care system: today and in the future
    • This one could have been subtitled “How Switzerland should Push and Pull“!
    • Webpage, primary report, and 5 April 2024 newsletter
    • Report author: Swiss Roundtable on Antibiotics
  • 3 Apr 2024: Towards Specific Commitments and Action in the Response to Antimicrobial Resistance
    • Yes, it’s a long title! And, there is a subtitle: Recommendations for consideration by UN Member States in the outcome document of the High-level Meeting on AMR in September 2024 
    • Webpage, report, and 19 Apr 2024 newsletter
    • There is also an important economic study that is used as supportive evidence. It is hard to find, but I do have this link: https://www.amrleaders.org/resources/m/item/annex-to-the-glg-report
    • Report author: GLG AMR (Global Leaders Group on Antimicrobial Resistance)
  • 23 May 2024: The Lancet Series on Antimicrobial Resistance: The need for sustainable access to effective antibiotics
    • A superb collection of papers covering the ideas of (i) Sustainable (ii) Access to (iii) Effective Antibiotics. Look closely at those 3 words: such a good summary … it’s a deep read, but well worth your time!
    • Webpage, 23 May 2024 newsletter, Fireside Chat with Ramanan Laxminarayan about the series and its messages
  • 12 Aug 2024: UK Subscription model goes live!
    • OK, it’s not a report per se but if it were it would be called “Here’s what can be done!”
    • The UK Subscription model really does set the pace for the rest of the world to follow
    • Webpage, 19 Aug 2024 newsletter
  • Aug 2024: Antibacterial pipeline trends and recommendations to enhance research and development
    • This policy brief does a good job of briefly (!) outlining 7 key points: the weak pipeline, the issues faced by developers, specific therapeutic gaps, the oral drug gap, the pediatric drug gap, the LMIC gap, and the non-traditional gap
    • Webpage, report, 1 Sep 2024 newsletter
    • Report author: WHO

• Reports (mostly) focused on agriculture and food chain
• January 2024: Tackling Antimicrobial Resistance in Food and Agriculture
  • A global survey of actions being taken by the Quadripartite, the Global Leaders Group, and the various National Action Plans on AMR in agricultural and food systems.
  • Webpage, report, and 27 Jan 2024 newsletter.
  • Report author: FAO

• About the AMR HLM (High-Level Meeting)
  • 23 Jan 2024: Resolution to support an HLM on AMR
  • 2 Feb 2024: Letter from the President of the General Assembly announcing the HLM